CTLA4 and cancer: More recently, Alison and Honjo, the 2018 Nobel prize winners in physiology, discovered immune checkpoint proteins, such as programmed cell death protein-1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4), which are key negative regulators of the immune system and cancer growth [27].